- Departments, Labs and Institutes
- Research Centers and Programs
- Clinical and Translational Research Center (CTRC)
The University of Texas MD Anderson Cancer Center Clinical and Translational Research Center (CTRC) is the dedicated MD Anderson site for complex biologically based new drug development. With its 32 room nursing area and adjacent full function laboratory, the 12,660 sq. ft. CTRC is an ideal location to perform intensive clinical trials with a focus on first-in-man, Phase I and Phase II studies with rigorous time points and pharmacologic testing. The CTRC provides a unique resource for physician-scientists and clinical investigators to develop new agents for cancer treatment by offering coordination of multidisciplinary research, regulatory compliance, budget development, intensive and time-sensitive monitoring of patients, phlebotomy, prompt accurate specimen processing, storage, tracking and shipment of specimens.
Created in 1990, The CTRC is MD Anderson’s dedicated unit in which to: Conduct early phase, complex, new drug research and develop new agents for the treatment of cancer and related diseases.
CCSG Support
The Cancer Center Support Grant (CCSG) provides partial funding for shared resources that are available to all cancer center members to facilitate research efforts.
Core Grant Citation
The CTRC is funded by NCI #CA16672. Publications should cite the Core grant in the acknowledgment section.
Notify CTRC when acknowledging the Core grant.
Related Resources
Contact Us
Main Building
1515 Holcombe Boulevard
Houston, TX 77030
Located on the 1st floor of the Main Building, near Elevator A.
CTRC Clinical Services
Clinical Administrative Director - Ad-Interim: Brenda Brown, RN, MSN, OCN
1515 Holcombe Boulevard Unit 365
Houston, TX 77030
Core Facility: 713-792-2144
ctrc@mdanderson.org
CTRC Laboratory Services
Laboratory Manager: Ryan Pepper, MB (ASCP)
Operations Manager: Traci Pitre, MBA
1515 Holcombe Boulevard Unit 386
Houston, TX 77030
Core Facility: 713-745-8287
ctrc@mdanderson.org